Rein Therapeutics RNTX
NASDAQ RNTX
$0.62 +0.03 (+4.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Restructuring Costs (2023)

Updated

Rein Therapeutics (RNTX) posted Restructuring Costs of -$12,000 for Q4 2023.

Analysis

Rein Therapeutics (RNTX) Restructuring Costs (2023) Analysis & Trends

For FY2023, Rein Therapeutics' Restructuring Costs came in at $928,000.

  • Quarterly Restructuring Costs has run from a low of -$88,000 in Q2 2023 to a high of $1.02 million in Q1 2023 over five years.
  • According to Business Quant data, Restructuring Costs for the three prior quarters was $6,000 (Q3 2023), -$88,000 (Q2 2023) and $1.02 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Rein Therapeutics 42.04 Mn -1.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -12,000.00
Sep 30, 2023 6,000.00
Jun 30, 2023 -88,000.00
Mar 31, 2023 1.02 Mn
API Access

Rein Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=RNTX&period=max&api_key=YOUR_API_KEY